background
respiratori
syncyti
viru
rsv
infect
second
import
caus
death
first
year
life
earli
rsv
infect
associ
develop
asthma
breastfeed
serum
igg
shown
protect
rsv
infect
yet
mani
infant
depend
bovin
milkbas
nutrit
present
lack
intact
immunoglobulin
object
investig
whether
igg
purifi
bovin
milk
bigg
modul
immun
respons
human
rsv
method
elisa
perform
analys
bind
bigg
human
respiratori
pathogen
bigg
hrsv
coat
plate
assess
dosedepend
bind
bigg
human
fcc
receptor
fccr
biggmedi
bind
myeloid
cell
hrsv
respect
epidermidi
rsv
use
test
biggmedi
bind
internalis
pathogen
myeloid
cell
final
abil
bigg
neutralis
infect
cell
hrsv
evalu
result
bigg
recognis
human
rsv
influenza
haemagglutinin
haemophilu
influenza
bigg
bound
fccrii
neutrophil
monocyt
macrophag
fccri
fccriii
could
bind
simultan
hrsv
human
fccrii
neutrophil
addit
human
neutrophil
dendrit
cell
internalis
pathogen
opsonis
bigg
final
bigg
could
prevent
infect
cell
hrsv
data
present
show
bigg
bind
hrsv
human
respiratori
pathogen
induc
effector
function
bind
human
fccrii
phagocyt
thu
bovin
igg
may
contribut
immun
protect
rsv
respiratori
syncyti
viru
rsv
infect
major
caus
death
first
year
life
especi
high
mortal
rate
african
asian
countri
upper
respiratori
tract
infect
urti
rsv
gener
caus
rel
mild
diseas
requir
treatment
infect
progress
howev
lower
respiratori
tract
infect
lrti
caus
sever
diseas
especi
prematur
infant
rsv
also
caus
recurr
infect
upper
respiratori
tract
import
complic
upper
respiratori
infect
middl
ear
inflamm
andrel
deaf
rsv
infect
associ
develop
asthma
later
age
common
caus
respiratori
tract
infect
haemophilu
influenza
type
b
hib
parainfluenza
viru
rhinoviru
influenza
viru
protect
immun
respiratori
pathogen
like
influenza
rsv
mediat
igg
iga
rsvspecif
serum
igg
level
neonat
invers
associ
increas
preval
rsv
infect
breastfeed
reduc
incid
sever
rsv
infect
addit
level
antiinfluenza
iga
breast
milk
correl
decreas
frequenc
respiratori
ill
fever
find
indic
pathogenspecif
antibodi
crucial
protect
respiratori
infect
oral
ingest
immunoglobulin
like
breastmilkderiv
iga
may
contribut
immun
airway
infect
human
bovin
milk
contain
high
level
immunoglobulin
import
protect
infant
infect
bacteria
virus
crossspeci
activ
human
bovin
immunerel
milk
protein
report
cow
milk
contain
bovin
igg
bigg
bind
gastrointestin
pathogen
also
infect
human
shigella
flexneri
escherichia
coli
clostridium
difficil
streptococcu
mutant
cryptosporidium
parvum
helicobact
pylori
rotaviru
present
howev
inform
bind
bovin
igg
human
respiratori
virus
infant
nutrit
bovin
milkbas
lack
intact
bigg
result
heat
treatment
process
investig
bigg
would
use
ingredi
formula
aim
present
studi
investig
specif
function
relev
bigg
rsv
human
respiratori
pathogen
abil
bigg
bind
human
fcc
receptor
induct
effector
function
human
myeloid
cell
bovin
milk
sampl
prepar
bigg
bigg
purifi
commerci
avail
bovin
colostrum
colostrum
igg
reflex
nutrit
bristol
uk
use
affit
tm
column
kementec
follow
protein
g
column
ml
amersham
bigg
elut
glycinehcl
ph
elut
buffer
neutralis
trishcl
ph
follow
dialys
pb
sterilis
mm
filter
fresh
milk
colostrum
sampl
suppli
frieslandcampina
netherland
maxisorb
elisapl
nunc
coat
mgml
pathogen
antigen
deriv
human
vaccin
influvac
mgml
abbott
biolog
acthib
sanofi
pasteur
msd
mgml
dtp
nederland
vaccin
instituut
ml
inactiv
rsv
rhinoviru
kindli
provid
prof
johnston
imperi
colleg
london
uk
plate
block
gelatinepb
wash
sampl
ad
titrat
plate
wash
four
time
hrpconjug
sheep
anti
bovin
abd
serotec
kidlington
uk
antihuman
igg
jackson
immunoresearch
west
grove
pa
usa
use
detector
antibodi
plate
wash
extens
develop
tmb
read
nm
inhibit
elisa
purifi
igg
human
plasma
intraven
immunoglobulin
pool
donor
ivig
sanquin
blood
suppli
netherland
bigg
equival
mgml
preincub
room
temperatur
twice
amount
use
coat
hrsv
vaccin
bind
f
protein
brsv
analys
commerci
elisa
accord
manufactur
descript
biox
diagnost
jemel
belgium
rsv
ad
cell
imdm
lglutamin
hepe
fsc
incub
six
day
cell
lyse
use
elisa
also
pegprecipit
rsv
lysat
prepar
slowli
ice
cold
mm
nacl
mm
edta
gl
tri
ad
rsvinfect
cell
stir
end
concentr
peg
mixtur
stir
three
hour
pegprecipit
viru
mixtur
centrifug
min
rpm
supernat
remov
pellet
taken
sucros
store
isol
cultur
human
myeloid
cell
ethic
approv
use
blood
sampl
obtain
institut
review
board
medic
ethic
committe
umc
utrecht
netherland
sanquin
blood
suppli
netherland
review
approv
obtain
prior
experi
conduct
accord
declar
helsinki
donor
provid
written
inform
consent
blood
sampl
use
anonym
blood
obtain
umc
utrecht
collect
heparin
vacutain
bd
bioscienc
buffi
coat
sanquin
blood
suppli
netherland
dilut
pb
dilut
blood
layer
top
histopaqueficol
gradient
centrifug
min
rpm
slow
acceler
without
brake
pbmc
pmn
harvest
wash
rpmi
red
blood
cell
lyse
ammonium
buffer
ph
umc
utrecht
pharmaci
minut
ice
monocyt
purifi
use
microbead
myltenyi
biotec
bergisch
gladbach
germani
accord
manufactur
prescript
follow
modif
cell
incub
half
volum
mac
buffer
bead
incub
minut
roller
monocyt
cultur
rpmi
contain
fc
differenti
macrophag
monocyt
cultur
overnight
presenc
ngml
ifnc
peprotech
rocki
hill
nj
usa
monocytederiv
dc
modc
differenti
five
day
influenc
ngml
gmcsf
peprotech
bind
bigg
cell
express
fccr
well
maxisorb
plate
nunc
coat
ig
nahpo
ph
overnight
cell
incub
mm
calcein
invitrogen
pb
pmn
label
hepe
min
pmn
min
wash
rpmi
contain
gelatin
calceinlabel
cell
ad
centrifug
rpm
min
allow
attach
min
min
pmn
rpmi
contain
gelatin
initi
fluoresc
fluoresc
sever
wash
step
record
excit
nm
emiss
nm
thermofish
scientif
fluoroskan
ascent
fl
fccrspecif
inhibit
bind
calceinlabel
cell
mgml
fab
fragment
clone
fccriii
fccrii
use
stabl
fccritransfect
cell
previous
shown
bind
human
igg
bigg
therefor
includ
studi
pathogenspecif
ig
cellbind
assay
well
maxisorb
plate
coat
pegprecipit
rsv
overnight
plate
wash
pb
block
gelatinepb
hour
wash
three
time
pbstween
bovin
human
igg
buffer
allow
bind
rsv
hour
room
temperatur
plate
wash
time
follow
wash
rpmi
contain
gelatin
assay
continu
describ
bind
igg
human
fcyr
fccrmediat
internalis
assay
cfuml
fitclabel
epidermidi
incub
ml
vari
concentr
ivig
bigg
overnight
twenti
ml
precool
cell
ad
incub
bacteria
ice
min
plate
wash
incub
min
macrophag
min
modc
ml
rpmi
cell
wash
stain
biotinyl
anti
fitc
antibodi
southern
biotec
follow
wash
streptavidin
apc
ebiosci
cell
wash
fix
pfapb
analys
fac
canto
ii
wash
step
perform
three
time
icecold
fac
buffer
cool
centrifug
rpm
minut
renillagfp
rsv
plaqu
form
unit
pfu
preincub
hour
ml
rpmi
fc
penstrep
presenc
absenc
antibodi
cool
min
ice
precool
pmn
cell
ml
rsvig
mixtur
ad
allow
bind
min
plate
plate
wash
incub
min
prewarm
rpmi
wash
cell
treat
trypsin
min
ice
remov
extracellular
rsv
cell
incub
twice
sec
acid
medium
rpmi
ph
fc
remov
fcr
bound
rsvig
min
centrifug
step
rpm
afterward
final
cell
wash
fix
pfa
pb
gfp
express
analys
flow
cytometri
cell
cell
cultur
imdm
fc
penstrep
seed
overnight
flatbottom
plate
renillagfp
rsv
pfu
preincub
hour
ml
medium
fc
presenc
absenc
antibodi
ad
cell
cell
trypsinis
hour
incub
gfp
express
analys
flow
cytometri
studi
bind
purifi
human
plasma
igg
ivig
bovin
colostrum
igg
bigg
human
rsv
hrsv
lysat
cell
control
rsv
infect
cell
coat
elisa
plate
dosedepend
bind
bigg
rsv
sd
background
observ
concentr
start
mgml
figur
ivig
bigg
also
bound
flu
hib
antigen
figur
pathogenspecif
bigg
could
detect
level
mg
ml
compar
bigg
less
ivig
requir
detect
pathogen
bind
bigg
rhinoviru
detect
high
igg
level
data
shown
hrsv
hib
influvacspecif
igg
could
also
detect
pool
bovin
milk
sampl
shown
test
specif
biggbind
human
respiratori
pathogen
inhibit
elisa
perform
experi
confirm
specif
bind
bigg
rsv
influenza
hib
figur
howev
bind
bigg
flu
could
also
partli
inhibit
hib
suggest
presenc
cross
reactiv
epitop
studi
bind
bigg
human
fccr
monocyt
incub
overnight
presenc
absenc
ifnc
enhanc
fccr
express
expos
platebound
bigg
human
monocyt
donor
bound
immobilis
bigg
well
ivig
increas
preincub
cell
ifnc
figur
bind
monocyt
bigg
dosedepend
compar
slightli
lower
compar
human
ivig
figur
also
bind
pmn
bigg
evalu
pmn
donor
bound
ivig
well
bigg
figur
identifi
receptor
involv
bind
pmn
bigg
unstimul
pmn
lack
fccri
incub
fccrii
fab
fccriii
f
ab
specif
block
mab
prior
addit
cell
igcoat
plate
figur
preincub
fccriiblock
fab
reduc
bind
pmn
bigg
three
donor
test
bind
pmn
presenc
absenc
fccriispecif
fab
compar
ivig
bigg
although
donorspecif
differ
observ
preincub
pmn
fccriiispecif
fab
result
slightli
decreas
bind
ivig
bigg
studi
whether
human
phagocyt
bind
bigg
captur
rsv
experi
perform
requir
bigg
simultan
bind
rsv
immobilis
plate
human
macrophag
figur
bind
cell
rsvspecif
ivig
bigg
dosedepend
lost
igg
boil
prior
addit
plate
bind
observ
plate
coat
gelatin
instead
rsv
data
shown
bovin
rsvspecif
igg
also
abl
bind
simultan
rsv
pmn
figur
next
pmn
preincub
anti
fccrii
andor
anti
fccriii
fab
prior
addit
rsvbound
ig
preincub
pmn
anti
fccrii
anti
fccriii
fab
reduc
bind
pmn
rsvspecif
ivig
bigg
figur
preincub
ig
rsv
complet
inhibit
cellbind
confirm
cellbind
assay
inde
rsvspecif
addit
extracellular
bind
pathogen
internalis
requir
effici
clearanc
pathogen
effici
induct
memori
cell
fitclabel
bacteria
epidermidi
use
model
biggmedi
internalis
pathogen
macrophag
modc
discrimin
extracellular
bound
bacteria
internalis
bacteria
apcconjug
antibodi
recognis
fitc
use
medium
epidermidi
left
nonopsonis
opsonis
differ
concentr
ivig
bigg
ad
macrophag
cell
allow
bind
bacteria
wash
incub
allow
internalis
allow
bind
internalis
minut
subsequ
cell
stain
apc
anti
fitc
ivig
bigg
enhanc
bind
bacteria
macrophag
indic
increas
percentag
cell
fitc
posit
figur
b
also
internalis
fitc
apc
bacteria
enhanc
ivig
bigg
increas
bind
internalis
dosedepend
observ
cell
incub
similarli
bigg
enhanc
internalis
epidermidi
modc
three
donor
figur
data
show
bigg
abl
enhanc
bind
well
internalis
pathogen
human
immun
cell
pmn
like
macrophag
play
crucial
role
elimin
opsonis
pathogen
investig
whether
pathogenopsonis
bigg
enhanc
internalis
human
pmn
gfplabel
hrsv
opsonis
bigg
absenc
antibodi
littl
internalis
hrsv
human
pmn
observ
measur
percentag
gfp
posit
cell
flow
cytometri
figur
contrast
preincub
hrsv
ivig
bigg
result
dosedepend
increas
hrsv
internalis
ivig
effect
bigg
two
highest
concentr
test
bigg
particularli
effect
lower
concentr
preterm
birth
children
receiv
intraven
palivizumab
prevent
rsv
infect
fprotein
epitop
recognis
palivizumab
seem
conserv
human
bovin
rsv
palivizumab
also
recognis
f
protein
bovin
rsv
data
shown
therefor
like
palivizumab
bigg
might
abl
prevent
infect
hrsv
aim
gfprenillarsv
preincub
bigg
ivig
palivizumab
ad
cell
hour
incub
cell
harvest
analys
gfp
express
flow
cytometri
ivig
bigg
dosedepend
neutralis
rsv
although
time
bigg
compar
ivig
need
inhibit
cell
infect
rsv
mgml
respect
figur
pathogenspecif
immunoglobulin
suppli
newborn
breastfeed
immunoglobulin
help
protect
neonat
infect
pathogen
bacteria
virus
neonat
especi
born
prematur
rel
vulner
pathogen
infect
respiratori
tract
aim
studi
whether
intact
bovin
milkderiv
immunoglobulin
modul
immun
respons
respiratori
pathogen
data
present
show
bigg
recognis
sever
pathogen
known
caus
infect
respiratori
tract
infant
addit
bigg
bound
human
fccrii
enhanc
phagocytosi
pathogen
human
myeloid
immun
cell
bovin
igg
shown
bind
human
rsv
could
even
prevent
infect
cell
human
rsv
vitro
cow
suscept
pathogen
like
bovin
rsv
transfer
bovin
rsvspecif
antibodi
colostrum
matur
milk
deliveri
observ
suggest
cow
inde
seem
develop
neutralis
antibodi
brsv
crossreact
hrsv
relev
note
even
though
signific
level
bigg
specif
human
respiratori
pathogen
detect
cow
immunis
human
pathogen
howev
common
practic
vaccin
calv
bovin
rsv
around
wean
maternalderiv
igg
level
decreas
data
suggest
rsv
protect
calf
brsv
immunis
may
give
rise
milk
potenti
protect
bovin
well
human
rsv
bigg
also
abl
neutralis
infect
cell
hrsv
compar
palivizumab
human
antirsv
therapeut
mab
ivig
significantli
higher
concentr
bigg
requir
neutralis
infect
cell
hrsv
palivizumab
often
given
prophylact
therefor
present
moment
hrsv
encount
neonat
direct
neutral
hrsv
oral
deposit
bigg
mucos
surfac
possibl
like
activ
b
cell
recircul
throughout
bodi
home
differ
tissu
tissu
specif
home
explain
oral
administr
antigenspecif
igg
lead
increas
presenc
memori
b
cell
organ
like
lung
breast
likewis
passiv
oral
vaccin
shown
induc
activ
immun
respons
gastrointestin
gi
tract
also
upper
airway
breast
tissu
therefor
bigg
consumpt
may
induc
adapt
immun
respiratori
pathogen
similar
manner
dietari
bigg
encount
swallow
respiratori
pathogen
gi
tract
tonsillar
crypt
waldey
ring
form
immunecomplex
effici
bind
dc
tissu
bigg
bind
rsv
may
lead
viral
uptak
fccrmediat
phagocytosi
therefor
may
facilit
enhanc
tcell
respons
bind
fccrii
report
gosselin
human
igg
interact
bigg
hfccrii
internalis
bigg
immunecomplex
observ
multipl
donor
indic
robust
phenomenon
tabl
shown
figur
bigg
could
bind
simultan
hrsv
fccrii
human
innat
immun
cell
modc
could
internalis
biggcoat
hrsv
need
antigen
present
confirm
earlier
find
demonstr
bind
bigg
human
fccrii
express
myeloid
cell
matur
dc
fccriimedi
antigen
uptak
present
well
dc
matur
crucial
activ
differenti
cell
result
bigg
may
facilit
adapt
cell
respons
thu
result
longlast
protect
airway
pathogen
via
tcell
depend
induct
pathogenspecif
iga
antibodi
upper
airway
current
find
base
variou
vitro
assay
requir
vivo
studi
show
formal
demonstr
like
ig
breast
milk
bigg
assist
develop
immun
memori
respons
anoth
aspect
need
studi
effect
bigg
induc
protect
immun
immunocompromis
individu
like
children
suffer
recurr
asthma
caus
viral
infect
newborn
immun
system
yet
matur
therefor
inclus
intact
bigg
infant
nutrit
may
contribut
induct
adapt
immun
airway
infect
interestingli
sever
epidemiolog
studi
link
consumpt
milk
reduc
incid
asthma
effect
later
shown
associ
consumpt
raw
milk
detect
intact
milk
protein
rsv
infect
may
predispos
infant
develop
asthma
later
age
would
like
specul
possibl
effect
describ
rsvspecif
bovin
antibodi
may
contribut
effect
raw
milk
consumpt
asthma
develop
although
nutrit
intervent
studi
need
formal
demonstr
dietari
bigg
contribut
protect
respiratori
pathogen
possibl
also
develop
asthma
vitro
data
report
support
concept
tabl
overview
donor
use
variou
assay
docx
